WARTMANN; Markus

Patent Applications and Registrations

Patent applications and USPTO patent grants for WARTMANN; Markus.The latest application filed is for "biaryl derivatives as yap/taz-tead protein-protein interaction inhibitors".

Company Profile

0.7.26

WARTMANN; Markus - Riehen CH

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Biaryl Derivatives As Yap/taz-tead Protein-protein Interaction Inhibitors App 20210299100 - BORDAS; Vincent ; et al.	2021-09-30
Pharmaceutical combinations Grant 10,130,629 - Buschmann , et al. November 20, 2	2018-11-20
Combination Therapy Containing A Pi3k-alpha Inhibitor And Fgfr Kinase Inhibitor For Treating Cancer App 20160095842 - Fritsch; Christine ; et al.	2016-04-07
Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent. App 20120283206 - Bruns; Christian ; et al.	2012-11-08
Combinations of Therapeutic Agents for Treating Cancer App 20110257206 - Burke; Gregory ; et al.	2011-10-20
Combinations comprising epothilones and pharmaceutical uses thereof Grant 8,008,330 - Chen , et al. August 30, 2	2011-08-30
Combinations Comprising Epothilones And Pharmaceutical Uses Thereof App 20110033458 - Hohneker; John Arthur ; et al.	2011-02-10
Cancer treatment with epothilones Grant 7,875,601 - O'Reilly , et al. January 25, 2	2011-01-25
Combinations Of Therapeutic Agents For Treating Cancer App 20100173934 - Burke; Gregory P. ; et al.	2010-07-08
Combination comprising a signal transduction inhibitor and an epothilone derivative Grant 7,723,339 - Brandt , et al. May 25, 2	2010-05-25
Tubulin Mutation Diagnostic App 20100055709 - Culver; Kenneth Wayne ; et al.	2010-03-04
Combinations Comprising Epothilones And Pharmaceutical Uses Thereof App 20090318390 - Chen; TianLing ; et al.	2009-12-24
Combinations comprising epothilones and pharmaceutical uses thereof Grant 7,612,052 - Rothermel , et al. November 3, 2	2009-11-03
Combination Comprising N-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl)-4-(3-p- Yridyl)-2pyrimidine-amine And A Chemotherapeutic Agent App 20090202541 - Bruns; Christian ; et al.	2009-08-13
Epothilone Compositions App 20090191264 - Sonntag; Jean-Claude ; et al.	2009-07-30
Cancer Treatment With Epothilones App 20090069394 - Dilea; Clifford ; et al.	2009-03-12
Tubulin Mutation Diagnostic App 20080131884 - Culver; Kenneth Wayne ; et al.	2008-06-05
Combinations Comprising Epothilones And Pharmaceutical Uses Thereof App 20080119529 - Chen; TianLing ; et al.	2008-05-22
Epothilone resistant cell lines App 20070134744 - Atadja; Peter Wisdom ; et al.	2007-06-14
Cancer treatment with epothilones App 20060235059 - Dilea; Clifford ; et al.	2006-10-19
Cancer treatment with epothilones App 20060223867 - O'Reilly; Terence ; et al.	2006-10-05
Cancer treatment with epothilones Grant 7,091,226 - O'Reilly , et al. August 15, 2	2006-08-15
Use of alpha-tubulin acetylation levels as a biomarker for protein deacetylase inhibitors App 20050227300 - Atadja, Peter Wisdom ; et al.	2005-10-13
Cancer treatment with epothilones App 20050165071 - O'Reilly, Terence ; et al.	2005-07-28
Epothilone compositions App 20050042275 - Sonntag, Jean-Claude ; et al.	2005-02-24
Combinations comprising epothilones and pharmaceutical uses thereof App 20040235796 - Chen, TianLing ; et al.	2004-11-25
Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-- 2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent App 20040167134 - Bruns, Christian ; et al.	2004-08-26
Combination comprising a signal transduction inhibitor and an epothilone derivative App 20040132754 - Brandt, Ralf ; et al.	2004-07-08
Epothilone resistant cell lines App 20040038324 - Atadja, Peter Wisdom. ; et al.	2004-02-26
Cancer treatment with epothilones App 20040024033 - O'Reilly, Terence ; et al.	2004-02-05
Cancer treatment with epothilones Grant 6,635,666 - O'Reilly , et al. October 21, 2	2003-10-21
Cancer treatment with epothilones App 20020028839 - O'Reilly, Terence ; et al.	2002-03-07

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.